Vicarious Surgical (RBOT) Other Non-Current Liabilities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Other Non-Current Liabilities came in at $553000.0 in Q3 2025, down 55.58% year-over-year from $1.2 million in Q3 2024, and down 34.17% quarter-over-quarter from $840000.0 in Q2 2025.
Analysis
Vicarious Surgical (RBOT) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Other Non-Current Liabilities for 6 consecutive years, with $553000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 55.58% year-over-year to $553000.0 in Q3 2025; TTM through Sep 2025 was $553000.0, a 55.58% decrease from a year earlier, with the FY2024 full-year figure at $787000.0, down 5.18% from the prior year.
- Other Non-Current Liabilities was $553000.0 for Q3 2025 at Vicarious Surgical, down from $840000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $129.6 million in Q3 2021 and troughed at $553000.0 in Q3 2025.
- A 5-year average of $20.7 million and a median of $6.0 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities surged 206.03% in 2021 and tumbled 93.31% in 2022, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $90.0 million in 2021, then plunged by 93.31% to $6.0 million in 2022, then plunged by 86.21% to $830000.0 in 2023, then dropped by 5.18% to $787000.0 in 2024, then decreased by 29.73% to $553000.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $553000.0 (Q3 2025), $840000.0 (Q2 2025), and $880000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 553,000.00 |
| Jun 30, 2025 | 840,000.00 |
| Mar 31, 2025 | 880,000.00 |
| Dec 31, 2024 | 787,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 2.70 Mn |
| Dec 31, 2023 | 830,000.00 |
| Sep 30, 2023 | 2.32 Mn |
| Jun 30, 2023 | 7.02 Mn |
| Mar 31, 2023 | 12.10 Mn |
| Dec 31, 2022 | 6.02 Mn |
| Sep 30, 2022 | 14.73 Mn |
| Jun 30, 2022 | 11.69 Mn |
| Mar 31, 2022 | 29.29 Mn |
| Dec 31, 2021 | 90.02 Mn |
| Sep 30, 2021 | 129.64 Mn |
| Jun 30, 2021 | 50.71 Mn |
| Mar 31, 2021 | 31.14 Mn |
| Dec 31, 2020 | 29.42 Mn |